Safety and efficacy of 0.01% and 0.1% low-dose atropine eye drop regimens for reduction of myopia progression in Danish children: a randomized clinical trial examining one-year effect and safety

Safety and efficacy of 0.01% and 0.1% low-dose atropine eye drop regimens for reduction of myopia progression in Danish children: a randomized clinical trial examining one-year effect and safety

Abstract Background To investigate the efficacy and safety of 0.1% and 0.01% low-dose atropine eye drops in reducing myopia progression in Danish children. Methods Investigator-initiated, placebo-controlled, double-masked, randomized clinical trial. Ninety-seven six- to twelve-year old myopic partic...

Full description

Bibliographic Details
Main Authors: Niklas Cyril Hansen, Anders Hvid-Hansen, Flemming Møller, Toke Bek, Dorte Ancher Larsen, Nina Jacobsen, Line Kessel
Format: Article
Language:English
Published: BMC 2023-10-01
Series:BMC Ophthalmology
Subjects:
Atropine
Myopia control
Spherical equivalent refraction
Axial length
Myopia
Eye drops
Online Access:https://doi.org/10.1186/s12886-023-03177-9

Internet

https://doi.org/10.1186/s12886-023-03177-9

Similar Items